NYLIM
EGRX

New York Life Investment Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

New York Life Investment Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,460
Closed -$335K – 1424
2022
Q4 		$335K Buy
11,460
+1,290
+13% +$37.7K ﹤0.01% 1100
2022
Q3 		$269K Buy
10,170
+747
+8% +$19.8K ﹤0.01% 1134
2022
Q2 		$419K Buy
+9,423
New +$419K ﹤0.01% 897